Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis

Ruxolitinib is an important treatment for steroid refractory graft-versus-host disease (SR-GVHD). Therefore, we reported the updated results of a systematic review and meta-analysis of ruxolitinib as treatment for SR-GVHD. In addition, we wanted to compare the efficacy and safety between children an...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Shuang, Huo, Wen-Xuan, Yang, Yang, Shen, Meng-Zhu, Mo, Xiao-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386528/
https://www.ncbi.nlm.nih.gov/pubmed/35990629
http://dx.doi.org/10.3389/fimmu.2022.954268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386528/
https://www.ncbi.nlm.nih.gov/pubmed/35990629
http://dx.doi.org/10.3389/fimmu.2022.954268

Ejemplares similares